KALA BIO, Inc. (KALA)

KALA BIO Statistics

Total Valuation

KALA BIO has a market cap or net worth of $37.04 million. The enterprise value is $27.16 million.

Market Cap	37.04M
Enterprise Value	27.16M

Important Dates

The next estimated earnings date is Tuesday, August 5, 2025, before market open.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

KALA BIO has 6.45 million shares outstanding. The number of shares has increased by 78.73% in one year.

Current Share Class	6.45M
Shares Outstanding	6.45M
Shares Change (YoY)	+78.73%
Shares Change (QoQ)	+35.17%
Owned by Insiders (%)	5.63%
Owned by Institutions (%)	30.13%
Float	3.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	6.49
P/TBV Ratio	6.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.99, with a Debt / Equity ratio of 5.67.

Current Ratio	1.99
Quick Ratio	1.95
Debt / Equity	5.67
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.25

Financial Efficiency

Return on equity (ROE) is -576.46% and return on invested capital (ROIC) is -60.45%.

Return on Equity (ROE)	-576.46%
Return on Assets (ROA)	-48.51%
Return on Invested Capital (ROIC)	-60.45%
Return on Capital Employed (ROCE)	-155.51%
Revenue Per Employee	n/a
Profits Per Employee	-$938,184
Employee Count	38
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.57% in the last 52 weeks. The beta is -1.89, so KALA BIO's price volatility has been lower than the market average.

Beta (5Y)	-1.89
52-Week Price Change	-24.57%
50-Day Moving Average	4.44
200-Day Moving Average	5.89
Relative Strength Index (RSI)	57.19
Average Volume (20 Days)	137,779

Short Selling Information

The latest short interest is 310,037, so 4.80% of the outstanding shares have been sold short.

Short Interest	310,037
Short Previous Month	296,392
Short % of Shares Out	4.80%
Short % of Float	8.41%
Short Ratio (days to cover)	6.61

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-39.31M
Pretax Income	-38.72M
Net Income	-35.65M
EBITDA	-39.05M
EBIT	-39.31M
Earnings Per Share (EPS)	-$7.62

Balance Sheet

The company has $42.22 million in cash and $32.35 million in debt, giving a net cash position of $9.87 million or $1.53 per share.

Cash & Cash Equivalents	42.22M
Total Debt	32.35M
Net Cash	9.87M
Net Cash Per Share	$1.53
Equity (Book Value)	5.71M
Book Value Per Share	0.88
Working Capital	22.74M

Cash Flow

In the last 12 months, operating cash flow was -$27.36 million and capital expenditures -$195,000, giving a free cash flow of -$27.56 million.

Operating Cash Flow	-27.36M
Capital Expenditures	-195,000
Free Cash Flow	-27.56M
FCF Per Share	-$4.27

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KALA BIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-78.73%
Shareholder Yield	-78.73%
Earnings Yield	-96.26%
FCF Yield	-74.40%

Analyst Forecast

The average price target for KALA BIO is $14.00, which is 143.90% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.00
Price Target Difference	143.90%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 21, 2022. It was a reverse split with a ratio of 0.02:1.

Last Split Date	Oct 21, 2022
Split Type	Reverse
Split Ratio	0.02:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2